Concepedia

Lon Smith

LS

Statistics

Publications

22

Citations

3.9K

H-Index

18

Active since

1993

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

South Texas Accelerated Research Therapeutics

Texas Oncology

Brooke Army Medical Center

Dana-Farber Cancer Institute

Lon Smith is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, oncology, and medicine.

Publications per year

1993–2021

22

Publications

22

Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2011 · 1K citations · Full text

, , +12

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik, Soonmo Peter Kang, Drew Rasco et al. · Clinical Cancer Research · 2015 · 794 citations

, , +17

The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer

Toshio Shimizu, Anthony W. Tolcher, Kyriakos P. Papadopoulos et al. · Clinical Cancer Research · 2012 · 432 citations

, , +17

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Mace L. Rothenberg, John R. Eckardt, John G. Kuhn et al. · Journal of Clinical Oncology · 1996 · 352 citations

, , +13

Phase I and pharmacokinetic trial of weekly CPT-11.

Mace L. Rothenberg, John G. Kuhn, Howard A. Burris et al. · Journal of Clinical Oncology · 1993 · 303 citations

, , +16

1–5 of 22